Related Experiment Video
Updated: Jan 11, 2026

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
Published on: November 18, 2022
From Wild Vegetable to Renal Protector: The Therapeutic Potential of Aralia elata (Miq.) Seem
Jingyi Wu1,2, Yue Liu1,2, Ziyun Xu1,2
1Department of Nephropathy Zhangjiagang Traditional Chinese Medicine (TCM) Hospital Affiliated to Nanjing University of Chinese Medicine Zhangjiagang Jiangsu China.
Abstract:
Aralia elata (Miq.) Seem. (A. elata) is a medicinal and edible wild vegetable, which has potential applications in the pharmaceutical and health food industries. Araloside A (Ara A) is a natural triterpenoid saponin extracted from A. elata. Chronic kidney disease (CKD) is an important public health problem worldwide. There is still a lack of effective drugs to delay the progression of renal injury. We experimentally found that Ara A can alleviate pathological renal injury, reduce proteinuria and improve renal dysfunction in model mice. This is associated with its ability to mitigate oxidative stress and regulate ferroptosis-related proteins. In vitro experiments, we found that Ara A can inhibit ferroptosis in podocytes and protect functional proteins. Mechanically, Ara A alleviated iron accumulation and lipid peroxidation in vivo and in vitro, and played a renal protective role by influencing the solute carrier family 7a member 11 (SLC7A11)/glutathione (GSH)/glutathione peroxidase 4 (GPX4) signaling pathway. Through cell and animal experiments, we have verified that Ara A, a component derived from A. elata, can delay glomerulosclerosis, with the inhibition of oxidative stress and ferroptosis as its potential mechanisms of action. These results provide evidence for the utilization of A. elata as a nutraceutical for the treatment of CKD.
More Related Videos
03:13Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Acute Kidney Injury IV: Diagnostic Studies and Prevention